O

Outlook Therapeutics

D
OTLK
USD
0.175
(2.6923%)
Market Closed
16,363.00
Volume
-3.98
EPS
-
Div Yield
-1.133277
P/E
157,901,370.30
Market Cap
Today
2.6923%
1 Week
15.885%
1 Month
30.703%
6 Months
-18.498%
12 Months
-33.263%
Year To Date
-15.506%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
V
VKTX
2.97
(4.5075%)
USD
Z
ZYNE
(%)
USD
A
ARWR
0.055
(0.2579%)
USD
A
AXSM
1.49
(1.6708%)
USD
S
SRNE
(%)
USD
T
TRVN
-2.02
(-44.9889%)
USD
A
ACAD
1.42
(8.993%)
USD
C
CRVS
-0.01
(-0.1135%)
USD
I
IMMP
-0.013
(-0.7046%)
USD

Title:
Outlook Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Do you need help or have a question?
Contact Us